Items where authors include "Brown, E."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Brown, E., Swinscoe, G., Lefteri, D.A. et al. (14 more authors) (2024) Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection. eLife, 13. e68404. ISSN 2050-084X
Ashford, F. orcid.org/0000-0002-2946-3864, Kuo, C.=W. orcid.org/0000-0002-1903-7618, Dunning, E. orcid.org/0009-0008-3373-9078 et al. (6 more authors) (2024) Cysteine post‐translational modifications regulate protein interactions of caveolin‐3. The FASEB Journal, 38 (5). e23535. ISSN 0892-6638
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Tavabie, O.D., Abbott, J., Abeysekera, K.W.M. et al. (97 more authors) (2024) Regional variations in inpatient decompensated cirrhosis mortality may be associated with access to specialist care: results from a multicentre retrospective study. Frontline Gastroenterology, 15 (1). pp. 3-13. ISSN 2041-4137
Dayimu, A. orcid.org/0000-0001-9998-7463, Gupta, A., Matin, R.N. et al. (25 more authors) (2024) A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM). European Journal of Cancer, 196. 113455. ISSN 0959-8049
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Tavabie, O.D., Abbott, J., Abeysekera, K.W. et al. (97 more authors) (2023) Defining characteristics and outcomes for patients with non-alcoholic fatty liver disease admitted to hospital with decompensated cirrhosis. Journal of Hepatology, 79 (4). e165-e167. ISSN 0168-8278
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Tavabie, O.D., Abeysekera, K.W.M., Brennan, P.N. et al. (291 more authors) (2023) Regional variation in characteristics of patients with decompensated cirrhosis admitted to hospitals in the UK. The Lancet Gastroenterology & Hepatology, 8 (7). pp. 604-606. ISSN 2468-1253
Kousathanas, A. orcid.org/0000-0001-6265-6521, Pairo-Castineira, E. orcid.org/0000-0002-2423-3090, Rawlik, K. orcid.org/0000-0002-0010-370X et al. (2377 more authors) (2022) Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature, 607. pp. 97-103. ISSN 0028-0836
Aprile, E., Aalbers, J., Agostini, F. et al. (140 more authors) (2021) 222Rn emanation measurements for the XENON1T experiment. The European Physical Journal C, 81 (4). 337. ISSN 1434-6044
Aprile, E., Aalbers, J., Agostini, F. et al. (137 more authors) (2021) Search for inelastic scattering of WIMP dark matter in XENON1T. Physical Review D, 103 (6). 063028. ISSN 2470-0010
Aprile, E., Aalbers, J., Agostini, F. et al. (135 more authors) (2021) Search for Coherent Elastic Scattering of Solar 8B Neutrinos in the XENON1T dark matter experiment. Physical Review Letters, 126 (9). 091301. ISSN 0031-9007
Aalbers, J., Agostini, F., Maouloud, S.E.M.A. et al. (163 more authors) (2020) Solar neutrino detection sensitivity in DARWIN via electron scattering. The European Physical Journal C, 80 (12). 1133. ISSN 1434-6044
Aprile, E., Aalbers, J., Agostini, F. et al. (136 more authors) (2020) Projected WIMP sensitivity of the XENONnT dark matter experiment. Journal of Cosmology and Astroparticle Physics, 2020 (11). 031. ISSN 1475-7516
Leary, J., Czyrnek-Delêtre, M., Alsop, A. et al. (12 more authors) (2020) Finding the niche: A review of market assessment methodologies for rural electrification with small scale wind power. Renewable and Sustainable Energy Reviews, 133. 110240. ISSN 1364-0321
Aprile, E., Aalbers, J., Agostini, F. et al. (136 more authors) (2020) Excess electronic recoil events in XENON1T. Physical Review D, 102 (7). 072004. ISSN 2470-0010
Aprile, E., Aalbers, J., Agostini, F. et al. (139 more authors) (2020) Energy resolution and linearity of XENON1T in the MeV energy range. The European Physical Journal C, 80 (8). 785. ISSN 1434-6044
Aprile, E., Aalbers, J. orcid.org/0000-0003-0030-0030, Agostini, F. et al. (130 more authors) (2019) Light dark matter search with ionization signals in XENON1T. Physical Review Letters, 123 (25). 251801. ISSN 0031-9007
Aprile, E., Aalbers, J., Agostini, F. et al. (131 more authors) (2019) Search for light dark matter interactions enhanced by the Migdal effect or bremsstrahlung in XENON1T. Physical Review Letters, 123 (24). 241803. ISSN 0031-9007
Aprile, E., Aalbers, J., Agostini, F. et al. (125 more authors) (2019) XENON1T dark matter data analysis: signal reconstruction, calibration, and event selection. Physical Review D, 100 (5). 052014. ISSN 2470-0010
Aprile, E., Aalbers, J., Agostini, F. et al. (131 more authors) (2019) The XENON1T data acquisition system. Journal of Instrumentation, 14 (07). P07016. ISSN 1748-0221
Piranavan, P., Li, Y., Brown, E. et al. (2 more authors) (2019) Immune checkpoint inhibitor-induced hypoparathyroidism associated with calcium-sensing receptor-activating autoantibodies. Journal of Clinical Endocrinology and Metabolism, 104 (2). pp. 550-556. ISSN 0021-972X
Tong, A., Manns, B., Wang, A.Y.M. et al. (202 more authors) (2018) Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney International, 94 (6). pp. 1053-1068. ISSN 0085-2538
Peytrignet, S., Denton, C.P., Lunt, M. et al. (60 more authors) (2018) Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology, 57 (2). pp. 370-381. ISSN 1462-0324
Herrick, A.L., Pan, X., Peytrignet, S. et al. (61 more authors) (2017) Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases. ISSN 0003-4967